Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
8.01
-0.11 (-1.35%)
At close: Mar 28, 2025, 4:00 PM
8.13
+0.12 (1.50%)
After-hours: Mar 28, 2025, 7:56 PM EDT

Avadel Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
169.1227.96--22.33
Upgrade
Revenue Growth (YoY)
504.79%----62.28%
Upgrade
Cost of Revenue
15.280.85--5.74
Upgrade
Gross Profit
153.8427.12--16.59
Upgrade
Selling, General & Admin
181.04151.7174.5268.532.41
Upgrade
Research & Development
15.213.2620.717.120.44
Upgrade
Operating Expenses
196.24164.9795.2285.653.25
Upgrade
Operating Income
-42.4-137.85-95.22-85.6-36.66
Upgrade
Interest Expense
-10.83-9.89-12.34-9.94-12.99
Upgrade
Interest & Investment Income
2.53--2.440.41
Upgrade
Other Non Operating Income (Expenses)
-1.891.22--
Upgrade
EBT Excluding Unusual Items
-50.7-145.85-106.34-93.1-49.25
Upgrade
Merger & Restructuring Charges
---3.350.050.04
Upgrade
Gain (Loss) on Sale of Investments
1.63-1.8-1.75-0.1-0.44
Upgrade
Gain (Loss) on Sale of Assets
----45.76
Upgrade
Legal Settlements
-----0.8
Upgrade
Other Unusual Items
--13.13---0.4
Upgrade
Pretax Income
-49.08-160.78-111.44-93.15-5.08
Upgrade
Income Tax Expense
-0.25-0.526.03-15.82-12.11
Upgrade
Earnings From Continuing Operations
-48.83-160.28-137.46-77.337.03
Upgrade
Net Income
-48.83-160.28-137.46-77.337.03
Upgrade
Net Income to Common
-48.83-160.28-137.46-77.337.03
Upgrade
Shares Outstanding (Basic)
9580605953
Upgrade
Shares Outstanding (Diluted)
9580605955
Upgrade
Shares Change (YoY)
18.67%33.41%2.66%6.54%46.89%
Upgrade
EPS (Basic)
-0.51-2.00-2.29-1.320.13
Upgrade
EPS (Diluted)
-0.51-2.00-2.29-1.320.13
Upgrade
Free Cash Flow
-46.91-128.51-71.02-77.34-48.83
Upgrade
Free Cash Flow Per Share
-0.49-1.60-1.18-1.32-0.89
Upgrade
Gross Margin
90.97%96.97%--74.29%
Upgrade
Operating Margin
-25.07%-492.97%---164.15%
Upgrade
Profit Margin
-28.88%-573.17%--31.47%
Upgrade
Free Cash Flow Margin
-27.74%-459.57%---218.64%
Upgrade
EBITDA
-39.72-136.08-93.72-84.78-34.97
Upgrade
EBITDA Margin
-23.48%----156.58%
Upgrade
D&A For EBITDA
2.681.771.490.821.69
Upgrade
EBIT
-42.4-137.85-95.22-85.6-36.66
Upgrade
EBIT Margin
-25.07%----164.15%
Upgrade
Advertising Expenses
----0.31
Upgrade
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q